Acute Myeloid Leukemia /Features
ISAL 2017: Developments in acute leukemias
The International Symposium on Acute Leukemias (ISAL) 2017 was, as always, filled with data, scientific developments and debate. To capture…
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
1 year
Innovative Medicines Initiative approves €40 million HARMONY project for better care of patients with hematologic malignancies
The Innovative Medicines Initiative (IMI) has approved HARMONY, a project that aims to foster better access and care for patients…
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Multiple Myeloma
Myelodysplastic Syndromes
Non-Hodgkin Lymphoma
1 year
New tyrosine kinase inhibitor shows promise
MRX-2843 is a tyrosine kinase inhibitor that targets the receptor tyrosine kinases MERTK and FLT3. Both MERTK and FLT3 are…
Acute Myeloid Leukemia
2 years
Cytarabine-daunorubicin liposome for injection: a potential new standard of care for elderly patients
The Phase III trial of a novel formulation of cytarabine-daunorubicin encapsulated in a liposome for injection, also referred to as…
Acute Myeloid Leukemia
2 years
